DrugAug 7, 2019
ImprimisRx NJ Timolol- Dorzolamide- Latanoprost P-F (0.5/2.0/0.005%) ophthalmic drops recall — FDA D-1579-2019
Subpotent Drug
Class IIFDA: TerminatedImprimisRx NJ
Recall history in this database
Classification mix: Class II: 2.
DrugAug 7, 2019
ImprimisRx NJ Timolol-Latanoprost P-F (0.5/0.005%) ophthalmic drops recall — FDA D-1578-2019
Subpotent Drug
Class IIFDA: TerminatedImprimisRx NJ
Understanding this recall history
This page summarizes recall records in which the official source identifies ImprimisRx NJ as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.